Eventide Asset Management - KEROS THERAPEUTICS INC ownership

KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 83 filers reported holding KEROS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of KEROS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18,490,400
-20.7%
580,0000.0%0.33%
-15.7%
Q2 2023$23,304,400
+81.9%
580,000
+93.3%
0.39%
+67.7%
Q1 2023$12,810,000
-29.4%
300,000
-29.8%
0.24%
-3.7%
Q2 2021$18,152,000
-31.0%
427,4140.0%0.24%
-37.4%
Q1 2021$26,307,000
+7.8%
427,414
+23.5%
0.39%
+4.3%
Q4 2020$24,407,000346,0000.37%
Other shareholders
KEROS THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 321,300$12,087,0004.99%
First Light Asset Management, LLC 598,213$22,505,0002.28%
Nantahala Capital Management 845,692$31,815,0002.06%
CHI Advisors LLC 200,229$7,533,0002.03%
Fairmount Funds Management LLC 272,498$10,251,0001.80%
Altium Capital Management LP 88,000$3,311,0001.21%
Orbimed Advisors 1,679,417$63,180,0001.17%
SPHERA FUNDS MANAGEMENT LTD. 206,819$7,781,0001.08%
Parkman Healthcare Partners LLC 99,927$3,759,0001.07%
Soleus Capital Management, L.P. 146,000$5,493,0000.75%
View complete list of KEROS THERAPEUTICS INC shareholders